Moreover, both ligands also synergistically regulated CD40-CD40L crosstalk between B-ALL cells and CD8+ T-cells leading to a PEG10-mediated enhanced production of IL-10 in CD40-activated leukemic cells, which impaired tumor-specific cytotoxic T-cell (CTL) responses (28). This evidence concerns the gene CD8A and neoplasm.